Celgene Corp. (CELG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 702.45m
  • Volume: 0

Latest ShareCast News

Bristol Myers acquires Celgene in $74bn pharma deal

By Iain Gilbert

Date: Thursday 03 Jan 2019

(Sharecast News) - US drugmaker Bristol-Myers Squibb reached a deal to acquire biotech group Celgene on Thursday in one of the largest acquisitions ever in the history of the pharmaceuticals industry.

Juno Therapeutics surges on Celgene deal

By Michele Maatouk

Date: Monday 22 Jan 2018

(ShareCast News) - Juno Therapeutics was set to surge at the open on Monday after agreeing for Celgene to buy the shares in the biopharmaceutical group it does not already own for around $9bn in cash.

Trump calls on drug giants to boost US production, lower prices

By Alexander Bueso

Date: Tuesday 31 Jan 2017

(ShareCast News) - The new US president called on the main pharmaceuticals firms to boost their production in the US and decrease their prices.

US close: Stocks struggle for direction after Ye... 15-Jul-2015 ShareCast
US open: Market struggles for direction in wake ... 15-Jul-2015 ShareCast
US pre-open: Futures edge higher ahead of Yellen... 15-Jul-2015 ShareCast
US broker round-up 13-Jun-2013 ShareCast
US broker round-up 28-Jan-2013 ShareCast
US broker round-up 13-Dec-2012 ShareCast
US broker round-up 21-Nov-2012 ShareCast
US broker round-up 22-Jun-2012 ShareCast
US broker round-up 10-Jan-2012 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Celgene Corp. Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 702.45m

Trades for --2024

Time Volume / Share Price
0 @ $0.00

Top of Page